Antiplatelet Drugs in the Management of Coronary Artery Disease - ScienceDirect
Atrial Fibrillation on Vitamin K Antagonist Oral Anticoagulant Undergoing Primary Percutaneous Coronary Intervention for ST-Elevation Acute Myocardial Infarction | SpringerLink
Cost implications of intraprocedural thrombotic events and bleeding in percutaneous coronary intervention: Results from the CHAMPION PHOENIX ECONOMICS Study | Semantic Scholar
Acute myocardial infarction - The Lancet
Bernardo Cortese M.D. - Page 10 of 22 - Interventional Cardiologist
PCI for STEMI - The Cardiology Advisor
Stent Thrombosis: A Clinical Perspective | JACC: Cardiovascular Interventions
Antiplatelet Drugs in the Management of Coronary Artery Disease - ScienceDirect
Health Economic Evaluation of an Ultrathin, Bioresorbable-Polymer Sirolimus-Eluting Coronary Stent Compared to a Thin, Durable-Polymer Everolimus-Eluting Stent - ScienceDirect
Impact of Intra-procedural Stent Thrombosis during Percutaneous Coronary Intervention: Insights from the CHAMPION PHOENIX Trial. | Request PDF
Impact of Intraprocedural Stent Thrombosis During Percutaneous Coronary Intervention: Insights From the CHAMPION PHOENIX Trial (Clinical Trial Comparing Cangrelor to Clopidogrel Standard of Care Therapy in Subjects Who Require Percutaneous Coronary ...
Cangrelor for treatment during percutaneous coronary intervention | Future Cardiology
Antithrombotic Approaches in Acute Coronary Syndromes: Optimizing Benefit vs Bleeding Risks - ScienceDirect
PDF) The management of antiplatelet therapy in acute coronary syndrome patients with thrombocytopenia: A clinical conundrum
Novel Antiplatelet Therapies for Atherothrombotic Diseases | Arteriosclerosis, Thrombosis, and Vascular Biology
Cardiovascular Medicine - Current trends in dual antiplatelet therapy: a 2017 update
Intra-Procedural Stent Thrombosis: A New Risk Factor for Adverse Outcomes in Patients Undergoing Percutaneous Coronary Intervention for Acute Coronary Syndromes | JACC: Cardiovascular Interventions
Cost implications of intraprocedural thrombotic events and bleeding in percutaneous coronary intervention: Results from the CHAMPION PHOENIX ECONOMICS Study | Semantic Scholar
Cangrelor for treatment during percutaneous coronary intervention | Future Cardiology
![Full text] Prevention of stent thrombosis: challenges and solutions | VHRM](https://www.dovepress.com/cr_data/article_fulltext/s43000/43357/img/Table4.jpg "Full text] Prevention of stent thrombosis: challenges and solutions | VHRM")
Full text] Prevention of stent thrombosis: challenges and solutions | VHRM
Cangrelor compared with clopidogrel improves efficiency without incre…
The evolution of antiplatelet therapy in cardiovascular disease | Nature Reviews Cardiology
Cost implications of intraprocedural thrombotic events and bleeding in percutaneous coronary intervention: Results from the CHAMPION PHOENIX ECONOMICS Study - Tamez - 2018 - Catheterization and Cardiovascular Interventions - Wiley Online Library
Impact of Intraprocedural Stent Thrombosis During Percutaneous Coronary Intervention: Insights From the CHAMPION PHOENIX Trial (Clinical Trial Comparing Cangrelor to Clopidogrel Standard of Care Therapy in Subjects Who Require Percutaneous Coronary ...
Study flow diagram. | Download Scientific Diagram
60145-x.fp.png "INCIDENCE AND PREDICTORS OF STENT THROMBOSIS AFTER PCI IN ACUTE MYOCARDIAL INFARCTION | Journal of the American College of Cardiology")
INCIDENCE AND PREDICTORS OF STENT THROMBOSIS AFTER PCI IN ACUTE MYOCARDIAL INFARCTION | Journal of the American College of Cardiology
Impact of Intraprocedural Stent Thrombosis During Percutaneous Coronary Intervention
